These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36543618)

  • 21. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
    Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
    Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cardiopulmonary effects of vasopressin compared with norepinephrine in septic shock.
    Gordon AC; Wang N; Walley KR; Ashby D; Russell JA
    Chest; 2012 Sep; 142(3):593-605. PubMed ID: 22518026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
    Haan BJ; Cadiz ML; Natavio AM
    Ann Pharmacother; 2020 Mar; 54(3):213-218. PubMed ID: 31625395
    [No Abstract]   [Full Text] [Related]  

  • 24. Vasopressin vs noradrenaline: Have we found the perfect recipe to improve outcome in septic shock?
    Chidambaram S; Goh EL; Rey VG; Khan MA
    J Crit Care; 2019 Feb; 49():99-104. PubMed ID: 30415181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydrocortisone versus vasopressin for the management of adult patients with septic shock refractory to norepinephrine: A multicenter retrospective study.
    Kulesza S; Gignac L; Colvin CA; Boll S; Giuliano C; Haan B; Allen B; Perez MM; Allen M; Edwin SB
    Pharmacotherapy; 2023 Aug; 43(8):787-794. PubMed ID: 37148191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of Timing and Catecholamine Requirements on Vasopressin Responsiveness in Critically ill Patients with Septic Shock.
    Jakowenko ND; Murata J; Kopp BJ; Erstad BL
    J Intensive Care Med; 2022 Nov; 37(11):1512-1519. PubMed ID: 35195486
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of vasopressin in the treatment of refractory septic shock.
    Kny KT; Ferreira MAP; Pizzol TDSD
    Rev Bras Ter Intensiva; 2018; 30(4):423-428. PubMed ID: 30570030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients: The VANCS II Randomized Clinical Trial.
    Hajjar LA; Zambolim C; Belletti A; de Almeida JP; Gordon AC; Oliveira G; Park CHL; Fukushima JT; Rizk SI; Szeles TF; Dos Santos Neto NC; Filho RK; Galas FRBG; Landoni G
    Crit Care Med; 2019 Dec; 47(12):1743-1750. PubMed ID: 31609774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Vasopressin for Vasoplegic Shock in Patients With Preoperative Left Ventricular Dysfunction After Cardiac Surgery: A Propensity-Score Analysis.
    Cheng Y; Pan T; Ge M; Chen T; Ye J; Lu L; Chen C; Zong Q; Ding Y; Wang D
    Shock; 2018 Nov; 50(5):519-524. PubMed ID: 29424795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of Vasopressin Responsiveness in Critically Ill Adults.
    Allen B; Kram B; Kram S; Schultheis J; Wolf S; Gilstrap D; Shapiro M
    Ann Pharmacother; 2018 Feb; 52(2):126-132. PubMed ID: 28853293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effects of short-term vasopressin infusion during severe septic shock.
    Patel BM; Chittock DR; Russell JA; Walley KR
    Anesthesiology; 2002 Mar; 96(3):576-82. PubMed ID: 11873030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of vasopressin and norepinephrine on vascular reactivity in a long-term rodent model of sepsis.
    Barrett LK; Orie NN; Taylor V; Stidwill RP; Clapp LH; Singer M
    Crit Care Med; 2007 Oct; 35(10):2337-43. PubMed ID: 17944022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selepressin in Septic Shock: A Step Toward Decatecholaminization?
    Asfar P; Russell JA; Tuckermann J; Radermacher P
    Crit Care Med; 2016 Jan; 44(1):234-6. PubMed ID: 26672929
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of Body Weight on Hemodynamic Response in Patients Receiving Fixed-Dose Vasopressin for Septic Shock.
    Hodge EK; Hughes DW; Attridge RL
    Ann Pharmacother; 2016 Oct; 50(10):816-23. PubMed ID: 27340145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comment on "A comparison of epinephrine and norepinephrine in critically Ill patients".
    Oud L
    Intensive Care Med; 2009 Jul; 35(7):1310; author reply 1311. PubMed ID: 19367392
    [No Abstract]   [Full Text] [Related]  

  • 36. Vasopressin in catecholamine-resistant septic and cardiogenic shock in very-low-birthweight infants.
    Meyer S; Löffler G; Polcher T; Gottschling S; Gortner L
    Acta Paediatr; 2006 Oct; 95(10):1309-12. PubMed ID: 16982509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of equipressor doses of norepinephrine, epinephrine, and phenylephrine on septic myocardial dysfunction.
    Ducrocq N; Kimmoun A; Furmaniuk A; Hekalo Z; Maskali F; Poussier S; Marie PY; Levy B
    Anesthesiology; 2012 May; 116(5):1083-91. PubMed ID: 22407285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasoactive drug support in septic shock.
    Dries DJ
    Shock; 2006 Nov; 26(5):529-30. PubMed ID: 17047528
    [No Abstract]   [Full Text] [Related]  

  • 39. Selepressin, a novel selective vasopressin V
    Russell JA; Vincent JL; Kjølbye AL; Olsson H; Blemings A; Spapen H; Carl P; Laterre PF; Grundemar L
    Crit Care; 2017 Aug; 21(1):213. PubMed ID: 28807037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing Vasopressin Use and Initiation Timing in Septic Shock: A Narrative Review.
    Sacha GL; Bauer SR
    Chest; 2023 Nov; 164(5):1216-1227. PubMed ID: 37479058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.